{"AllianceGenome": "10597", "HGNC": "10597", "MIM": "603415", "_id": "6335", "_version": 2, "accession": {"genomic": ["AC074101.5", "AC107082.3", "AC108146.3", "AJ580918.1", "AJ580919.1", "CH471058.2", "CP068276.2", "DQ148960.1", "NC_000002.12", "NC_060926.1", "NG_012798.1"], "protein": ["AAT85833.1", "AAT85834.1", "AAT85835.1", "AAY14794.1", "AAZ77737.1", "ABI51981.1", "CAA58042.1", "CAC84537.1", "CAC84550.1", "CAC84551.1", "CAE45644.1", "CAE45645.1", "EAX11314.1", "EAX11315.1", "EAX11316.1", "NP_001352465.1", "NP_002968.2", "Q15858.3", "XP_011509918.1", "XP_011509919.1", "XP_011509920.1", "XP_011509921.1", "XP_016860158.1", "XP_054199295.1", "XP_054199296.1", "XP_054199297.1", "XP_054199298.1", "XP_054199299.1", "XP_054199300.1", "XP_054199301.1"], "rna": ["AJ277393.1", "AJ310882.1", "AJ310883.1", "AJ310897.1", "AK307549.1", "AL517958.3", "AY682084.1", "AY682085.1", "AY682086.1", "BU742924.1", "DQ857292.1", "NM_001365536.1", "NM_002977.4", "X82835.1", "XM_011511616.4", "XM_011511617.3", "XM_011511618.3", "XM_011511619.3", "XM_017004669.2", "XM_054343320.1", "XM_054343321.1", "XM_054343322.1", "XM_054343323.1", "XM_054343324.1", "XM_054343325.1", "XM_054343326.1", "XR_001738886.2"], "translation": [{"protein": "CAC84550.1", "rna": "AJ310882.1"}, {"protein": "XP_011509921.1", "rna": "XM_011511619.3"}, {"protein": "AAT85834.1", "rna": "AY682085.1"}, {"protein": "XP_011509920.1", "rna": "XM_011511618.3"}, {"protein": "NP_002968.2", "rna": "NM_002977.4"}, {"protein": "XP_054199299.1", "rna": "XM_054343324.1"}, {"protein": "AAT85835.1", "rna": "AY682086.1"}, {"protein": "XP_054199301.1", "rna": "XM_054343326.1"}, {"protein": "NP_001352465.1", "rna": "NM_001365536.1"}, {"protein": "XP_054199298.1", "rna": "XM_054343323.1"}, {"protein": "XP_011509919.1", "rna": "XM_011511617.3"}, {"protein": "XP_054199295.1", "rna": "XM_054343320.1"}, {"protein": "XP_054199300.1", "rna": "XM_054343325.1"}, {"protein": "XP_054199297.1", "rna": "XM_054343322.1"}, {"protein": "AAT85833.1", "rna": "AY682084.1"}, {"protein": "XP_054199296.1", "rna": "XM_054343321.1"}, {"protein": "XP_016860158.1", "rna": "XM_017004669.2"}, {"protein": "CAC84537.1", "rna": "AJ310897.1"}, {"protein": "CAA58042.1", "rna": "X82835.1"}, {"protein": "XP_011509918.1", "rna": "XM_011511616.4"}, {"protein": "ABI51981.1", "rna": "DQ857292.1"}, {"protein": "CAC84551.1", "rna": "AJ310883.1"}]}, "alias": ["ETHA", "FEB3B", "GEFSP7", "HSAN2D", "NE-NA", "NENA", "Nav1.7", "PN1", "SFNP"], "clingen": {"_license": "https://www.clinicalgenome.org/docs/terms-of-use/", "clinical_validity": {"classification": "refuted", "classification_date": "2021-03-09T16:36:49.218Z", "disease_label": "epilepsy", "gcep": "Epilepsy Gene Curation Expert Panel", "moi": "AD", "mondo": "MONDO:0005027", "online_report": "https://search.clinicalgenome.org/kb/gene-validity/CGGV:assertion_72a91ef6-e052-44a4-b14e-6a5ba93393ff-2021-03-09T163649.218Z", "sop": "SOP8"}}, "ensembl": {"gene": "ENSG00000169432", "protein": ["ENSP00000304748", "ENSP00000386306", "ENSP00000393141", "ENSP00000413212", "ENSP00000494071", "ENSP00000495601", "ENSP00000495983", "ENSP00000496086", "ENSP00000499341", "ENSP00000499663"], "transcript": ["ENST00000303354", "ENST00000409672", "ENST00000452182", "ENST00000454569", "ENST00000472119", "ENST00000642356", "ENST00000643319", "ENST00000645283", "ENST00000645815", "ENST00000645907", "ENST00000646694", "ENST00000667201", "ENST00000667991"], "translation": [{"protein": "ENSP00000495601", "rna": "ENST00000642356"}, {"protein": "ENSP00000386306", "rna": "ENST00000409672"}, {"protein": "ENSP00000304748", "rna": "ENST00000303354"}, {"protein": "ENSP00000495983", "rna": "ENST00000645907"}, {"protein": "ENSP00000499341", "rna": "ENST00000667201"}, {"protein": "ENSP00000494071", "rna": "ENST00000643319"}, {"protein": "ENSP00000496086", "rna": "ENST00000645283"}, {"protein": "ENSP00000413212", "rna": "ENST00000454569"}, {"protein": "ENSP00000393141", "rna": "ENST00000452182"}, {"protein": "ENSP00000499663", "rna": "ENST00000667991"}], "type_of_gene": "protein_coding"}, "entrezgene": "6335", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 50.6643352145, "exp_mis": 549.038797863, "exp_syn": 208.284545663, "lof_z": 3.15414367251339, "mis_z": -0.688046766263253, "mu_lof": 4.0955190914e-06, "mu_mis": 5.21881655423e-05, "mu_syn": 1.92541880711e-05, "n_lof": 28.0, "n_mis": 582.0, "n_syn": 236.0, "p_li": 9.30185484244833e-13, "p_null": 0.00149780156150877, "p_rec": 0.998502198437561, "syn_z": -1.19053914908374}, "bp": 5934, "cds_end": 167168266, "cds_start": 167055181, "n_exons": 26, "nonpsych": {"exp_lof": 45.4003135958, "exp_mis": 496.477308466, "exp_syn": 188.061823678, "lof_z": 3.26495148383891, "mis_z": -0.464564978176116, "mu_lof": 4.0955190914e-06, "mu_mis": 5.21881655423e-05, "mu_syn": 1.92541880711e-05, "n_lof": 23.0, "n_mis": 517.0, "n_syn": 205.0, "p_li": 5.67355632616921e-10, "p_null": 0.000540744572873917, "p_rec": 0.99945925485977, "syn_z": -0.777643275585539}, "nontcga": {"exp_lof": 46.5667619756, "exp_mis": 505.071302569, "exp_syn": 191.577371764, "lof_z": 2.8285391510897, "mis_z": -0.39744972935881, "mu_lof": 4.0955190914e-06, "mu_mis": 5.21881655423e-05, "mu_syn": 1.92541880711e-05, "n_lof": 27.0, "n_mis": 523.0, "n_syn": 221.0, "p_li": 1.08393489757577e-12, "p_null": 0.00586764617400641, "p_rec": 0.99413235382491, "syn_z": -1.34595709322844}, "transcript": "ENST00000409672.1"}, "exons": [{"cdsend": 166311756, "cdsstart": 166198671, "chr": "2", "position": [[166195186, 166199864], [166203954, 166204225], [166204359, 166204464], [166226566, 166226704], [166227669, 166227723], [166228690, 166228972], [166233339, 166233462], [166238093, 166238267], [166242501, 166242656], [166251764, 166251885], [166272398, 166272875], [166276982, 166277339], [166278139, 166278313], [166280356, 166280595], [166281678, 166281808], [166284452, 166284824], [166286335, 166286623], [166288436, 166288643], [166293230, 166293372], [166294598, 166294662], [166303089, 166303302], [166304237, 166304329], [166305791, 166305920], [166306509, 166306599], [166306955, 166307074], [166311498, 166311806], [166375696, 166375944]], "strand": -1, "transcript": "NM_001365536", "txend": 166375944, "txstart": 166195186}, {"cdsend": 166311756, "cdsstart": 166198671, "chr": "2", "position": [[166195186, 166199864], [166203954, 166204225], [166204359, 166204464], [166226566, 166226704], [166227669, 166227723], [166228690, 166228972], [166233339, 166233462], [166238093, 166238267], [166242501, 166242656], [166251764, 166251885], [166272398, 166272875], [166276982, 166277339], [166278139, 166278313], [166280356, 166280595], [166281678, 166281808], [166284485, 166284824], [166286335, 166286623], [166288436, 166288643], [166293230, 166293372], [166294598, 166294662], [166303089, 166303302], [166304237, 166304329], [166305791, 166305920], [166306509, 166306599], [166306955, 166307074], [166311498, 166311806], [166375696, 166375987]], "strand": -1, "transcript": "NM_002977", "txend": 166375987, "txstart": 166195186}], "exons_hg19": [{"cdsend": 167168266, "cdsstart": 167055181, "chr": "2", "position": [[167051696, 167056374], [167060464, 167060735], [167060869, 167060974], [167083076, 167083214], [167084179, 167084233], [167085200, 167085482], [167089849, 167089972], [167094603, 167094777], [167099011, 167099166], [167108274, 167108395], [167128908, 167129385], [167133492, 167133849], [167134649, 167134823], [167136866, 167137105], [167138188, 167138318], [167140962, 167141334], [167142845, 167143133], [167144946, 167145153], [167149740, 167149882], [167151108, 167151172], [167159599, 167159812], [167160747, 167160839], [167162301, 167162430], [167163019, 167163109], [167163465, 167163584], [167168008, 167168316], [167232206, 167232454]], "strand": -1, "transcript": "NM_001365536", "txend": 167232454, "txstart": 167051696}, {"cdsend": 167168266, "cdsstart": 167055181, "chr": "2", "position": [[167051696, 167056374], [167060464, 167060735], [167060869, 167060974], [167083076, 167083214], [167084179, 167084233], [167085200, 167085482], [167089849, 167089972], [167094603, 167094777], [167099011, 167099166], [167108274, 167108395], [167128908, 167129385], [167133492, 167133849], [167134649, 167134823], [167136866, 167137105], [167138188, 167138318], [167140995, 167141334], [167142845, 167143133], [167144946, 167145153], [167149740, 167149882], [167151108, 167151172], [167159599, 167159812], [167160747, 167160839], [167162301, 167162430], [167163019, 167163109], [167163465, 167163584], [167168008, 167168316], [167232206, 167232497]], "strand": -1, "transcript": "NM_002977", "txend": 167232497, "txstart": 167051696}], "generif": [{"pubmed": 14985375, "text": "mutations in SCN9A cause primary erythermalgia"}, {"pubmed": 15385606, "text": "We show that mutations in Na(v)1.7 associated with erythermalgia produce a hyperpolarizing shift in activation and slow deactivation, and cause an increased amplitude of the current produced by Na(v)1.7 in response to slow, small polarizations"}, {"pubmed": 15929046, "text": "familial erythromelalgia is a channelopathy caused by mutations in the gene encoding the Na(v)1.7 sodium channel which lead to altered channel function"}, {"pubmed": 15955112, "text": "detected missense sequence variants in SCN9A to be present in primary erythermalgia patients"}, {"pubmed": 16088330, "text": "Nav1.7 is the VGSCalpha most strikingly upregulated (approximately 20-fold) in prostate neoplasms"}, {"pubmed": 16216943, "text": "primary erythermalgia may be caused by hyperexcitability of nav1.7."}, {"pubmed": 16392115, "text": "A single amino acid substitution (L858F) in the DIIS4-S5 linker of Na(v)1.7 was present in two children whose parents were asymptomatic. The asymptomatic father was genetically mosaic for the mutation."}, {"pubmed": 16988069, "text": "These results provide a physiologic basis for the linkage to erythermalgia of an Na(v)1.7 mutation that substitutes one uncharged residue for another within an S4 segment of the channel."}, {"pubmed": 17008310, "text": "the linker between S4 and S5 in domain I of Nav1.7 modulates gating of this channel, and a larger side chain at position 241 interferes with its gating mechanisms"}, {"pubmed": 17135418, "text": "Ala863Pro mutant Nav1.7 channels produce hyperexcitability in dorsal root ganglia neurons, which contributes to the pathophysiology of erythromelalgia/erythermalgia."}, {"pubmed": 17167479, "text": "An SCN9A channelopathy causes congenital inability to experience pain"}, {"pubmed": 17167479, "text": "data suggest that SCN9A is an essential and non-redundant requirement for nociception in humans"}, {"pubmed": 17294067, "text": "A Taiwanese family with the characteristic features of erythromelalgia is described. Genetic linkage studies established that the disease locus maps to human chromosome 2 and a novel mutation SCN9A(I136V)"}, {"pubmed": 17404832, "text": "results suggest that the enhancement of TTX-sensitive sodium current density in differentiated NG108-15 cells is mainly due to the increase in the expression of the TTX-sensitive voltage-gated Na+ channel, NaV1.7"}, {"pubmed": 17410110, "text": "A patient represents a typical case of juvenile onset primary familial erythromelalgia, a rare disorder that has been shown in some patients to be caused by a mutation to the SCN9A gene."}, {"pubmed": 17430993, "text": "Mutations in SCN9A may mediate variabiilty in lidocaine sensitivity in erythromelalgia patients."}, {"pubmed": 17470132, "text": "identified 10 mutations in the SCN9A gene encoding the sodium channel protein Nav1.7 in congenital indifference to pain"}, {"pubmed": 17597096, "text": "A stop codon mutation in SCN9A causes lack of pain sensation."}, {"pubmed": 17928139, "text": "In rectal hypersensitivity, Na(v)1.7 immunoreactive nerve fibres were significantly increased in mucosal, sub-mucosal, and muscle layers"}, {"pubmed": 17950472, "text": "The contribution of Na(v)1.7 to acquired and inherited pain states and the absence of motor, cognitive and cardiac deficits in patients lacking this channel make it an attractive target for the treatment of neuropathic pain."}, {"pubmed": 17985268, "text": "This study describe a boy with erythermalgia whose painful attacks began in infancy. We found a novel mutation of SCN9A."}, {"pubmed": 18036246, "text": "VGSC activity has a significant intermediary role in potentiating effect of EGF in human prostate cancer"}, {"pubmed": 18060017, "text": "highlights of recent developments and discussion of the critical role of Na(v)1.7 in pain sensation in humans [review]"}, {"pubmed": 18070139, "text": "review: a series of SCN9A mutations resulting in gain-of-function phenotypes presenting with the phenotype of enhanced pain sensitivity."}, {"pubmed": 18070140, "text": "review: Congenital Indifference to Pain patients assessed are homozygous or compound heterozygous for nonsense mutations at various locations throughout SCN9A, resulting in an early stop codon"}, {"pubmed": 18079277, "text": "State- and use-dependent block of neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine is reported."}, {"pubmed": 18171466, "text": "The isoleucine-136-valine substitution alters channel gating and kinetic properties, contributing to erythromelalgia."}, {"pubmed": 18337362, "text": "alternative splicing of human Na(v)1.7 can specifically modulate the biophysical properties and cAMP-mediated regulation of this channel"}, {"pubmed": 18347287, "text": "We detected a low SCN9A mutation rate in patients with primary erythermalgia suggesting that pain syndromes in the skin may have a polygenic basis"}, {"pubmed": 18426592, "text": "the increased axonal expression and augmentation of Nav1.7 at intact and remodeling/demyelinating nodes within the painful human dental pulp"}, {"pubmed": 18439623, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 18439623, "text": "variations of SCN9A can lead to complete inability to sense pain"}, {"pubmed": 18518989, "text": "two missense mutations in Nav1.7 in a family with erythermalgia; one of the two variants (L858F) is causal for erythermalgia; the second variant (P610T) may modify the phenotype"}, {"pubmed": 18599537, "text": "This study demonstrated that mutations within D3/S4-S5 affect inactivation of Nav1.7 in a residue-specific manner and disruption of the fast-inactivated state by these mutations can be more moderate than previously indicated."}, {"pubmed": 18676988, "text": "Observational study of gene-disease association and gene-gene interaction. (HuGE Navigator)"}, {"pubmed": 18803825, "text": "Met1627Lys mutant SCN9A channels render dorsal root ganglion neurons hyperexcitable and provide a link between altered channel biophysics and pain in paroxysmal extreme pain disorder."}, {"pubmed": 18945915, "text": "Erythromelalgia and paroxysmal extreme pain disorder mutants(Nav1.7 A1632E)are part of a physiological continuum that can produce a continuum of clinical phenotypes."}, {"pubmed": 18978189, "text": "Na(V)1.7 is expressed in aorta after balloon injury, suggesting a potential role for Na(V)1.7 in the progression of intimal hyperplasia"}, {"pubmed": 19304393, "text": "Here we describe a woman with insensitivity to pain with two novel mutations in the SCN9A gene, coding for the Nav1.7 channel."}, {"pubmed": 19557861, "text": "study reports a novel Nav1.7 mutation (V400M) in a three-generation Canadian family with inherited erythromelalgia in which pain is relieved by carbamazepine"}, {"pubmed": 19633428, "text": "the additive effects observed on ramp currents from exon 5 splicing and the PEPD mutation (I1461T) are likely to impact the disease phenotype"}, {"pubmed": 19699781, "text": "In trigeminal neuralgia (TN) there is a reduction in the expression of Nav1.7 and an increase in the expression of Nav1.3, Nav1.8 expression not significantly different; TN can be, at least in part, a channelopathy."}, {"pubmed": 19763161, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 19763161, "text": "This study provides evidence for a role of SCN9A in human epilepsies, both as a cause of febrile seizure and as a partner with SCN1A mutations."}, {"pubmed": 19800314, "text": "inherited form of erythromelalgia mutation L823R, which introduces an additional positive charge into the S4 voltage sensor of domain II, was characterized."}, {"pubmed": 20033988, "text": "The results suggested that polymorphisms( R1150W) in the Na(V)1.7 channel may influence nociceptor excitability."}, {"pubmed": 20038812, "text": "study showed that a paroxysmal extreme pain disorder mutation in the Nav1.7 channel, a paramyotonia congenita mutation in the Nav1.4 channel & a long-QT3/SIDS mutation in the NAV1.5 channel all increased the amplitude of resurgent sodium currents"}, {"pubmed": 20074229, "text": "Despite the fact that the SCN9A gene is an excellent candidate, we did not find evidence that it plays a major role in familial complex regional pain syndrome"}, {"pubmed": 20146699, "text": "several different disease manifestations arising from changes within the Na(v)1.7 channel (Review)"}, {"pubmed": 20212137, "text": "Individuals experience differing amounts of pain, per nociceptive stimulus, on the basis of their SCN9A rs6746030 genotype."}, {"pubmed": 20212137, "text": "Observational study of gene-disease association. (HuGE Navigator)"}, {"pubmed": 20379614, "text": "Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)"}, {"pubmed": 20429905, "text": "Results provide evidence for differential roles of the DIII/S4-S5 linker N- and C-termini in channel inactivation and activation, and demonstrate the cellular basis for pain in patients carrying these mutations."}, {"pubmed": 20478850, "text": "This study shows that a change in relative expression of splice isoforms can contribute to time-dependent manifestation of the functional phenotype of a sodium channelopathy."}, {"pubmed": 20529324, "text": "Na v 1.7 sodium channel may play a significant role in inflammatory dental pain."}, {"pubmed": 20628234, "text": "This mutation expands the body of evidence supporting the critical role of the Na1.7 channel in the perception of pain."}, {"pubmed": 20635406, "text": "This study has identified critical amino acids needed for the normal subcellular localization and function of Na(v)1.7."}, {"pubmed": 20692858, "text": "Congenital insensitivity to pain was associated with two novel SCN9A mutations which most likely resulted in a Nav1.7 channelopathy."}, {"pubmed": 20959280, "text": "We present a PEM case with R1150W polymorphism in SCN9A and a five-year remission was achieved by chemical lumbar sympathectomy (CLS)."}, {"pubmed": 21031562, "text": "R1150W amino acid change in the Na(V)1.7 alpha-chain is involved in genetic susceptibility to pain, but it does not appear to have a major role in osteoarthritic-specific pain."}, {"pubmed": 21094958, "text": "A heterozygous change of n.4648 T-C in exon 27 caused W1550R, affecting a highly conserved amino acid, predicting damage in the transmembrane S2 region, repeat IV.SCN9A mutations cause pain syndromes other than IEM & PEPD."}, {"pubmed": 21115638, "text": "The paroxysmal extreme pain disorder associated Nav1.7 missense mutations M1627K, T1464I and V1299F increase Navbeta4 peptide-mediated resurgent sodium currents, in contrast to the erythromelalgia associated I848T and L858H Nav1.7 missense mutations."}, {"pubmed": 21232038, "text": "Depolarizing pulses that increased slow inactivation of Na(v)1.7 voltage-gated sodium channels also reduced lidocaine inhibition."}, {"pubmed": 21441906, "text": "Na(v)1.7 is not only necessary for pain sensation but is also an essential requirement for odour perception in both mice and humans"}, {"pubmed": 21698661, "text": "Gain of function mutations in sodium channel Nanu1.7 which render dorsal root ganglion neurons hyperexcitable and are present in a substantial proportion of patients meeting strict criteria for idiopathic small fiber neuropathy."}, {"pubmed": 21705421, "text": "This study suggested that NS-Del channels can increase neuronal excitability at potentials where slow inactivation has not overwhelmed the effects of enhanced activation and the persistent currents that facilitate the generation of action potentials."}, {"pubmed": 21715690, "text": "Fine-tuning of immature dendritic cell (DC)functions by voltage-gated sodium channel Nav1.7 emerges as a new regulatory mechanism modulating migration and cytokine responses of DC subsets."}, {"pubmed": 21939494, "text": "Data suggest that mutations in SCN9A may be cause partial deletion of pain perception, and the novel polymorphism V1104L may have a predictive role in the pain sensation of healthy individuals."}, {"pubmed": 21984269, "text": "Loss-of-function mutations in Na(v)1.7 are extremely rare, and invariably cause congenital inability to perceive pain (Review)"}, {"pubmed": 22033523, "text": "We present a severe case of progressive primary erythromelalgia caused by a new de novo heterozygous missense mutation (c.2623C>G) of the SCN9A gene which substitutes glutamine 875 by glutamic acid (p.Q875E). To our knowledge, this mutation has not been previously reported in the literature. [review]"}, {"pubmed": 22136189, "text": "results demonstrate intra- and interfamily phenotypic diversity in pain syndromes produced by a gain-of-function variant of NaV1.7."}, {"pubmed": 22286749, "text": "Description of a novel syndrome of distal pain, dysautonomia, small hands and small feet in a kindred with a novel missense SCN9A mutation that causes multiple gain-of-function changes in NaV1.7, including markedly enhanced persistent current."}, {"pubmed": 22348792, "text": "In this group of Mexican women, a disabling form of fibromyalgia is associated with a SCN9A sodium channel gene variant, raising the possibility that patients with severe fibromyalgia may have a dorsal root ganglia sodium channelopathy."}, {"pubmed": 22539570, "text": "The I739V Nav1.7 variant in a patient with biopsy-confirmed idiopathic small fiber neuropathy impairs slow-inactivation within dorsal root ganglion neurons and increases their excitability."}, {"pubmed": 22875917, "text": "The results of this study suggested that Sodium channel Na(v)1.7 is essential for lowering heat pain threshold after burn injury."}, {"pubmed": 22911851, "text": "Splicing can change the way that Na(V) channels interact with beta subunits."}, {"pubmed": 23006801, "text": "No association between a non-synonymous polymorphism in SCN9A and chronic widespread pain was observed in multiple population-based cohorts."}, {"pubmed": 23102778, "text": "These data strongly suggest that pain perception in at least a subset of patients with interstitial cystitis/bladder pain syndrome is influenced by the rs6746030 polymorphism in the SCN9A voltage-gated sodium channel."}, {"pubmed": 23129781, "text": "We also found a splicing junction variant of SCN91 in all 19 patients WITH enital insensitivity to pain"}, {"pubmed": 23149731, "text": "Structural modelling reveals that Na(v)1.7-S241T is ~2.4 A apart from V400M in the folded channel, and thermodynamic analysis demonstrates energetic coupling of V400M and S241T during activation."}, {"pubmed": 23232607, "text": "This review reveled the evidence that Na(V)1.7 is a major contributor to pain signalling in humans."}, {"pubmed": 23280954, "text": "In small-fiber neuropathy, [isoleucine]228[methionine] variant Nav1.7 channel contributes to impaired regeneration and degeneration of sensory axons."}, {"pubmed": 23292638, "text": "2 gain-of-function mutations in the 4th domain of Nav1.7, A1746G & W1538R, caused hyperpolarization and affected age of erythromelalgia onset."}, {"pubmed": 23364568, "text": "Patients carrying the SCN9A 3312Tallele presented with lower postoperative pain sensitivity in the presence of a similar surgical pain stimulus"}, {"pubmed": 23383113, "text": "A novel SCN9A mutation responsible for primary erythromelalgia and is resistant to the treatment of sodium channel blockers."}, {"pubmed": 23450472, "text": "More patients have suffered dyskinesis pain. A 3448 (C/T) mutation of SCN9A gene may be related to pathogenesis of pain in Parkinsonism."}, {"pubmed": 23536180, "text": "Structural and functional demonstration of the importance of radial tuning of the sodium channel S6 helix for the channel activation."}, {"pubmed": 23596073, "text": "We identified a novel homozygous mutation in SCN9A from 2 Japanese families with autosomal recessive hereditary sensory and autonomic neuropathy type IId."}, {"pubmed": 23836888, "text": "a novel regulatory mechanism that utilizes CRMP2 SUMOylation to choreograph NaV1.7 trafficking."}, {"pubmed": 23850641, "text": "This study demonstrated that a variant of NaV1.7 associated with painful neuropathy depolarizes resting membrane potential and produces an enhanced inward current during interspike intervals, thereby contributing to DRG neuron hyperexcitability"}, {"pubmed": 23874707, "text": "A working link between nociception and olfaction via Nav1.7 in the gain-of-function direction."}, {"pubmed": 23895530, "text": "Role of the SCN9A mutations in genetic epilepsy with febrile seizures plus and Dravet syndrome"}, {"pubmed": 23986482, "text": "EGF/EGFR-mediated upregulation of Nav1.7 is necessary for invasive behaviour in these cells."}, {"pubmed": 24082113, "text": "Data indicate that micro-SLPTX-Ssm6a, a unique 46-residue peptide from centipede venom, potently inhibits NaV1.7."}, {"pubmed": 24202110, "text": "Recent studies have shown that mutations in the SCN9A gene are the cause of a subgroup of idiopathic small fiber neuropathies and that polymorphisms of SCN9A are associated with an increase in susceptibility to pain."}, {"pubmed": 24311784, "text": "persistent and resurgent currents are likely to determine whether a mutation in Nav1.7 leads to IEM or PEPD."}, {"pubmed": 24401712, "text": "This study show a linear correlation between the level of Nav1.7 conductance and current threshold in DRG neurons."}, {"pubmed": 24820863, "text": "The co-segregation of the I739V variant in the affected members of the family provides evidence, for the first time, that paroxysmal itch can be related to a mutation in sodium channel gene."}, {"pubmed": 24866741, "text": "Our study demonstrates an example of predicting the treatment effect of mexiletine in patients suffering from a specific gain-of-function mutation in NaV1.7"}, {"pubmed": 25008557, "text": "NaV1.7 is expressed in both dorsal root ganglion neurons and pancreatic beta cells.Vulnerability of dorsal root ganglia neurons due to NaV1.7 mutations increases risk of neuropathy."}, {"pubmed": 25209274, "text": "Sodium channel Nav1.7, encoded by SCN9A, is expressed in DRG neurons and regulates their excitability."}, {"pubmed": 25240195, "text": "PKC can increase sodium resurgent currents through phosphorylation of a conserved Serine residue located in the domain III-IV linker of hNav1.7"}, {"pubmed": 25285947, "text": "The novel p.L1612P Nav1.7 mutation expands the paroxysmal extreme pain disorder spectrum with a unique combination of clinical symptoms and electrophysiological properties"}, {"pubmed": 25575597, "text": "Nav1.7 mutations are associated with pain syndromes including erythromelalgia."}, {"pubmed": 25585270, "text": "Association of SCN9A variants with neuropathic pain and pain severity suggests a role of SCN9A in the disease etiology of neuropathic pain"}, {"pubmed": 25957174, "text": "the activity of mutant Nav1.7 channels in smooth muscle cells of skin vasculature and innervating sensory and sympathetic fibers contribute to the skin reddening"}, {"pubmed": 25995458, "text": "Novel SCN9A mutations altering Nav1.7 channel activation were found families with inherited erythromelalgia, paroxysmal extreme pain disorder and congenital insensitivity to pain."}, {"pubmed": 26168879, "text": "These findings provided evidence that the variability of basal pain sensitivity was associated with SCN9A polymorphisms in the general population."}, {"pubmed": 26486037, "text": "We report the case of a 6-year-old girl with a SCN9A mutation who presented with both gain of function and loss of function phenotypes, including congenital corneal anesthesia."}, {"pubmed": 26634308, "text": "Nav1.7 deletion has profound effects on gene expression, leading to an upregulation of enkephalin precursor Penk mRNA and met-enkephalin protein in sensory neurons."}, {"pubmed": 26752484, "text": "Postoperative pain was affected by SCN9A genetic variability in gynecological surgical patients."}, {"pubmed": 26861708, "text": "We exploited existing technologies in a novel manner to identify selective antagonists of NaV1.7. A full-deck high-throughput screen was developed for both NaV1.7 and cardiac NaV1.5 channels using a cell-based membrane potential dye FLIPR assay"}, {"pubmed": 26920677, "text": "Patients with the SCN9A mutation with inherited erythromelalgia were characterized for the pain phenotype among individuals."}, {"pubmed": 27129258, "text": "report the engineering of highly potent and selective inhibitors of the Nav1.7 channel based on tarantula ceratotoxin-1 (CcoTx1). We utilized a combination of directed evolution, saturation mutagenesis, chemical modification, and rational drug design to obtain higher potency and selectivity to the Nav1.7 channel"}, {"pubmed": 27162340, "text": "Mutant cycle analysis with modified saxitoxins reveals specific interactions critical to attaining high-affinity inhibition of human NaV1.7."}, {"pubmed": 27174182, "text": "Authors introduced mutations into Nav1.7 and Nav1.6 that either enhance or impair slow inactivation (SI) in order to investigate their effects on resurgent currents. The results show that enhanced SI is accompanied by impaired resurgent currents, which suggests that SI may interfere with open-channel block."}, {"pubmed": 27311819, "text": "This is the first study to demonstrate that binding of ProTx-II to the lipid membrane is directly linked to its potency as an hNaV1.7 channel inhibitor."}, {"pubmed": 27413160, "text": "This study showed that gain-of-function attributes at the channel level and differential effects of physiologically relevant thermal stimuli on the excitability of DRG neurons expressing mutant and WT Nav1.7 channels, suggesting a cellular mechanism for warmth-triggered pain episodes in Erythromelalgia patients."}, {"pubmed": 27503742, "text": "A novel Nav1.9 mutation, p.Arg222His, was identified in patients with early-onset pain in distal extremities including joints and gastrointestinal disturbances, but was absent from an asymptomatic blood relative."}, {"pubmed": 27529686, "text": "Results indicate that Nav 1.7 promotes gastric cancer progression through MACC1-mediated upregulation of NHE1."}, {"pubmed": 27747863, "text": "The four congenital insensitivity to pain families, while not closely related, belong to the same ethnic group and clan, and the SCN9A mutation may be specific, if not unique to this group"}, {"pubmed": 27821467, "text": "the results of this study provide mechanistic evidence for a time-dependent increase in intracellular [Ca2+]i and energetic compromise in the neurites of dorsal root ganglia neurons expressing G856D mutant Nav1.7 channels."}, {"pubmed": 27940916, "text": "cross-talk between distinct CRMP2 posttranslational modifications is a key factor in determining NaV1.7 trafficking and localization"}, {"pubmed": 27956748, "text": "We performed functional studies on NaV1.7 C1143F.  Our study indicates the involvement of inherited SCN9A variants and partial loss-of-function of NaV1.7 channels in the etiology of rare familial ASD."}, {"pubmed": 28103821, "text": "Genetic polymorphisms of SCN9A are associated with protection for severe neuropathy induced by oxaliplatin in digestive cancer."}, {"pubmed": 28162808, "text": "the FGF13/Nav1.7 complex is essential for sustaining the transmission of noxious heat signals"}, {"pubmed": 28381558, "text": "Gain-of-function mutation of a voltage-gated sodium channel NaV1.7 associated with peripheral pain and impaired limb development"}, {"pubmed": 28424991, "text": "This study demonstrated that the higher expression Nav1.7 in human Dorsal Root Ganglion Neurons."}, {"pubmed": 28639956, "text": "Hereditary Small fiber neuropathy has been described with pathogenic mutations in sodium channels [Nav1.7 (mostly), which lead to hyperexcitability of dorsal root ganglions. These gain-of-function mutations result in degeneration of small fibers."}, {"pubmed": 28990532, "text": "F826Y mutation of Nav1.7 gene is associated with DRG neurons hyperexcitable and contributes to the pathogenesis of Erythromelalgia."}, {"pubmed": 29106681, "text": "Common Missense Variant of SCN9A Gene Is Associated with Pain Intensity in Patients with Chronic Pain from Disc Herniation"}, {"pubmed": 29176367, "text": "this study reveals an important link between painful Diabetic peripheral neuropathy and NaV1.7, suggesting that rare NaV1.7 variants may predispose patients with diabetic neuropathy to developing neuropathic pain."}, {"pubmed": 29446526, "text": "This work delineates a new pathway, which involves the NF-kappaB transcription factor, SCN9A expression, plasma membrane depolarization, increased calcium, the Rb/E2F pathway and mitotic gene repression in the regulation of senescence. This work thus provides new insight into the involvement of ion channels and plasma membrane potential in the control of senescence."}, {"pubmed": 29790812, "text": "Nav1.7 is a substrate for Fyn kinase."}, {"pubmed": 30037327, "text": "Each CIP subject was homozygous for a putatively nonsense variant, R1488*, in SCN9A."}, {"pubmed": 30081699, "text": "It demonstrates the enzyme/substrate nature of Ubc9/CRMP2 binding and identify hot spots on CRMP2 that may form the basis of future drug discovery campaigns disrupting the CRMP2-Ubc9 interaction to recapitulate allosteric regulation of NaV1.7 for pain relief."}, {"pubmed": 30307573, "text": "no association of evaluated polymorphisms of Nav1.7 or NTRK1 and trigeminal neuralgia diagnosis or pain severity was observed"}, {"pubmed": 30316835, "text": "Zebrafish embryos, transiently overexpressing the pathogenic human SCN9A mutations, have a significantly decreased density of small-nerve fibers."}, {"pubmed": 30416015, "text": "SCN9A mutations resulting in greater hyperpolarizing shifts in Nav1.7 sodium channels correlated with symptom onset at younger ages and comorbidities were more common in children with SCN9A mutations."}, {"pubmed": 30554136, "text": "The frequency of (potentially) pathogenic variants was 5.1% (n=58/1139) for SCN9A, 3.7% (n=42/1139) for SCN10A and 2.9% (n=33/1139) for SCN11A in pure small fibre neuropathy."}, {"pubmed": 30765606, "text": "this study reports the cryo-electron microscopy structures of the human Nav1.7-beta1-beta2 complex bound to two combinations of pore blockers and gating modifier toxins (GMTs), tetrodotoxin with protoxin-II and saxitoxin with huwentoxin-IV, both determined at overall resolutions of 3.2 angstroms."}, {"pubmed": 30795902, "text": "Patients with congenital insensitivity to pain due to NaV1.7 mutations have a functional absence of nociceptors."}, {"pubmed": 31372899, "text": "SCN9A Epileptic Encephalopathy Mutations Display a Gain-of-function Phenotype and Distinct Sensitivity to Oxcarbazepine."}, {"pubmed": 31394368, "text": "Mutations in theSCN9A gene may be linked with fever-associated seizures or epilepsy."}, {"pubmed": 31439884, "text": "Anomalous enhancement of resurgent Na(+) currents at high temperatures by SCN9A mutations underlies the episodic heat-enhanced pain in inherited erythromelalgia."}, {"pubmed": 31851560, "text": "The small fiber neuropathy NaV1.7 I228M mutation: impaired neurite integrity via bioenergetic and mitotoxic mechanisms, and protection by dexpramipexole."}, {"pubmed": 32062735, "text": "Novel mutation of SCN9A gene causing generalized epilepsy with febrile seizures plus in a Chinese family."}, {"pubmed": 32295642, "text": "Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients."}, {"pubmed": 32403129, "text": "Analysis of SCN9A Gene Variants for Acute and Chronic Postoperative Pain and Morphine Consumption After Total Hysterectomy."}, {"pubmed": 32404070, "text": "Paroxysmal extreme pain disorder in family with c.3892G > T (p.Val1298Phe) in the SCN9A gene mutation - case report."}, {"pubmed": 32420800, "text": "Novel SCN9A missense mutations contribute to congenital insensitivity to pain: Unexpected correlation between electrophysiological characterization and clinical phenotype."}, {"pubmed": 32571169, "text": "Investigation of binding modes of spider toxin-human voltage-gated sodium channel subtybe 1.7."}, {"pubmed": 32601768, "text": "Painful and painless mutations of SCN9A and SCN11A voltage-gated sodium channels."}, {"pubmed": 32663327, "text": "Uncoupling sodium channel dimers restores the phenotype of a pain-linked Nav 1.7 channel mutation."}, {"pubmed": 33216760, "text": "No association between SCN9A and monogenic human epilepsy disorders."}, {"pubmed": 33232657, "text": "Structural Basis for High-Affinity Trapping of the NaV1.7 Channel in Its Resting State by Tarantula Toxin."}, {"pubmed": 33361158, "text": "Phosphorylation of a chronic pain mutation in the voltage-gated sodium channel Nav1.7 increases voltage sensitivity."}, {"pubmed": 33493520, "text": "Engineering of highly potent and selective HNTX-III mutant against hNav1.7 sodium channel for treatment of pain."}, {"pubmed": 33774271, "text": "In silico development of potential therapeutic for the pain treatment by inhibiting voltage-gated sodium channel 1.7."}, {"pubmed": 33895391, "text": "Mutations in the sodium channel genes SCN1A, SCN3A, and SCN9A in children with epilepsy with febrile seizures plus(EFS+)."}, {"pubmed": 34090020, "text": "Rare mutations in ATL3, SPTLC2 and SCN9A explaining hereditary sensory neuropathy and congenital insensitivity to pain in a Brazilian cohort."}, {"pubmed": 34799533, "text": "Congenital insensitivity to pain: a novel mutation affecting a U12-type intron causes multiple aberrant splicing of SCN9A."}, {"pubmed": 34957475, "text": "Nav1.7 is required for normal C-low threshold mechanoreceptor function in humans and mice."}, {"pubmed": 35413129, "text": "Non-canonical endogenous expression of voltage-gated sodium channel NaV 1.7 subtype by the TE671 rhabdomyosarcoma cell line."}, {"pubmed": 35878056, "text": "Unwinding and spiral sliding of S4 and domain rotation of VSD during the electromechanical coupling in Nav1.7."}, {"pubmed": 36111846, "text": "Ocular manifestations among patients with congenital insensitivity to pain due to variants in PRDM12 and SCN9A genes."}, {"pubmed": 36539035, "text": "The fates of internalized NaV1.7 channels in sensory neurons: Retrograde cotransport with other ion channels, axon-specific recycling, and degradation."}, {"pubmed": 36722722, "text": "Nav1.7 P610T mutation in two siblings with persistent ocular pain after corneal axon transection: impaired slow inactivation and hyperexcitable trigeminal neurons."}, {"pubmed": 36730021, "text": "Integrative miRNA-mRNA profiling of human epidermis: unique signature of SCN9A painful neuropathy."}, {"pubmed": 36792043, "text": "NaV1.7 channels are expressed in the lower airways of the human respiratory tract."}, {"pubmed": 36981004, "text": "SCN9A rs6746030 Polymorphism and Pain Perception in Combat Athletes and Non-Athletes."}, {"pubmed": 37231219, "text": "Novel SCN9A variant associated with congenital insensitivity to pain."}, {"pubmed": 37345838, "text": "A novel mutation in the SCN9A gene associated with congenital insensitivity to pain, anhidrosis, and mild cognitive impairment."}, {"pubmed": 37555797, "text": "Genetic, electrophysiological, and pathological studies on patients with SCN9A-related pain disorders."}, {"pubmed": 37721535, "text": "Erythromelalgia caused by the missense mutation p.Arg220Pro in an alternatively spliced exon of SCN9A (NaV1.7)."}, {"pubmed": 37903281, "text": "Structural basis for severe pain caused by mutations in the voltage sensors of sodium channel NaV1.7."}, {"pubmed": 38329587, "text": "COMT and SCN9A gene variants do not contribute to chronic low back pain in Mexican-Mestizo patients."}, {"pubmed": 38394191, "text": "Identification and In-Silico study of non-synonymous functional SNPs in the human SCN9A gene."}, {"pubmed": 38743485, "text": "Role of NaV1.7 in postganglionic sympathetic nerve function in human and guinea-pig arteries."}, {"pubmed": 38999942, "text": "Genetic Analysis of SCN11A, SCN10A, and SCN9A in Familial Episodic Pain Syndrome (FEPS) in Japan and Proposal of Clinical Diagnostic Criteria."}], "genomic_pos": {"chr": "2", "end": 166376001, "ensemblgene": "ENSG00000169432", "start": 166195185, "strand": -1}, "genomic_pos_hg19": {"chr": "2", "end": 167232503, "start": 167051695, "strand": -1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006814", "pubmed": 7720699, "qualifier": "involved_in", "term": "sodium ion transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0006954", "qualifier": "involved_in", "term": "inflammatory response"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0007623", "qualifier": "involved_in", "term": "circadian rhythm"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009636", "qualifier": "involved_in", "term": "response to toxic substance"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0009791", "qualifier": "involved_in", "term": "post-embryonic development"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0019233", "pubmed": 17145499, "qualifier": "involved_in", "term": "sensory perception of pain"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0035725", "qualifier": "involved_in", "term": "sodium ion transmembrane transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:0035725", "pubmed": 17145499, "qualifier": "involved_in", "term": "sodium ion transmembrane transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0048266", "qualifier": "involved_in", "term": "behavioral response to pain"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050965", "qualifier": "involved_in", "term": "detection of temperature stimulus involved in sensory perception of pain"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0050974", "qualifier": "involved_in", "term": "detection of mechanical stimulus involved in sensory perception"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0086002", "qualifier": "involved_in", "term": "cardiac muscle cell action potential involved in contraction"}], "CC": [{"evidence": "IBA", "gocategory": "CC", "id": "GO:0001518", "qualifier": "part_of", "term": "voltage-gated sodium channel complex"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0005886", "pubmed": 17145499, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0030424", "qualifier": "located_in", "term": "axon"}], "MF": [{"category": "MF", "evidence": "IBA", "id": "GO:0005248", "qualifier": "enables", "term": "voltage-gated sodium channel activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0005248", "pubmed": 17145499, "qualifier": "enables", "term": "voltage-gated sodium channel activity"}, {"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 37117223, "qualifier": "enables", "term": "protein binding"}]}, "homologene": {"genes": [[8364, 100486750], [9031, 395946], [9544, 574119], [9598, 459704], [9606, 6335], [9615, 100855710], [9913, 533065], [10090, 20274], [10116, 78956]], "id": 2237}, "interpro": [{"desc": "Ion transport domain", "id": "IPR005821", "short_desc": "Ion_trans_dom"}, {"desc": "Voltage-dependent channel domain superfamily", "id": "IPR027359", "short_desc": "Volt_channel_dom_sf"}, {"desc": "Voltage-gated cation channel calcium and sodium", "id": "IPR043203", "short_desc": "VGCC_Ca_Na"}, {"desc": "Voltage-gated Na+ ion channel, cytoplasmic domain", "id": "IPR024583", "short_desc": "Na_trans_cytopl"}, {"desc": "IQ motif, EF-hand binding site", "id": "IPR000048", "short_desc": "IQ_motif_EF-hand-BS"}, {"desc": "Voltage gated sodium channel, alpha subunit", "id": "IPR001696", "short_desc": "Na_channel_asu"}, {"desc": "Sodium ion transport-associated domain", "id": "IPR010526", "short_desc": "Na_trans_assoc_dom"}, {"desc": "Voltage-gated sodium channel alpha subunit, inactivation gate", "id": "IPR044564", "short_desc": "Na_chnl_inactivation_gate"}], "ipi": ["IPI00154944", "IPI00479414", "IPI00745570"], "map_location": "2q24.3", "name": "sodium voltage-gated channel alpha subunit 9", "other_names": ["hNE-Na", "neuroendocrine sodium channel", "peripheral sodium channel 1", "sodium channel protein type 9 subunit alpha", "sodium channel protein type IX subunit alpha", "sodium channel, voltage-gated, type IX, alpha polypeptide", "sodium channel, voltage-gated, type IX, alpha subunit", "voltage-gated sodium channel alpha subunit Nav1.7", "voltage-gated sodium channel subunit alpha Nav1.7"], "pantherdb": {"HGNC": "10597", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"WormBase": "WBGene00001187", "ortholog_type": "O", "panther_family": "PTHR45628", "taxid": 6239, "uniprot_kb": "Q8MQA1"}, {"FlyBase": "FBgn0001991", "ortholog_type": "O", "panther_family": "PTHR45628", "taxid": 7227, "uniprot_kb": "Q24270"}, {"SGD": "S000003449", "ortholog_type": "O", "panther_family": "PTHR45628", "taxid": 4932, "uniprot_kb": "P50077"}, {"PomBase": "SPAC6F6.01", "ortholog_type": "O", "panther_family": "PTHR45628", "taxid": 4896, "uniprot_kb": "O14234"}], "uniprot_kb": "Q15858"}, "pathway": {"kegg": {"id": "hsa04742", "name": "Taste transduction - Homo sapiens (human)"}, "reactome": [{"id": "R-HSA-1266738", "name": "Developmental Biology"}, {"id": "R-HSA-373760", "name": "L1CAM interactions"}, {"id": "R-HSA-397014", "name": "Muscle contraction"}, {"id": "R-HSA-422475", "name": "Axon guidance"}, {"id": "R-HSA-445095", "name": "Interaction between L1 and Ankyrins"}, {"id": "R-HSA-5576891", "name": "Cardiac conduction"}, {"id": "R-HSA-5576892", "name": "Phase 0 - rapid depolarisation"}, {"id": "R-HSA-9675108", "name": "Nervous system development"}, {"id": "R-HSA-9709957", "name": "Sensory Perception"}, {"id": "R-HSA-9717189", "name": "Sensory perception of taste"}, {"id": "R-HSA-9717207", "name": "Sensory perception of sweet, bitter, and umami (glutamate) taste"}]}, "pdb": ["5EK0", "6J8G", "6J8H", "6J8I", "6J8J", "6N4Q", "6N4R", "6NT3", "6NT4", "6VXO", "6W6O", "7K48", "7W9K", "7W9L", "7W9M", "7W9P", "7W9T", "7XM9", "7XMF", "7XMG", "7XVE", "7XVF", "8F0P", "8F0Q", "8F0R", "8F0S", "8G1A", "8I5B", "8I5G", "8I5X", "8I5Y", "8J4F", "8S9B", "8S9C", "8THG", "8THH", "8XMM", "8XMN", "8XMO"], "pfam": ["PF00520", "PF11933", "PF06512"], "pharmgkb": "PA35010", "pharos": {"target_id": 18702, "tdl": "Tclin"}, "pir": "S54771", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256039", "relationship": "is"}, {"id": "GNF256040", "relationship": "is"}, {"id": "GNF256041", "relationship": "is"}, {"id": "GNF256042", "relationship": "is"}], "GNF_hs-Origene": {"id": "GNF038127", "relationship": "similar to"}, "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF090823", "relationship": "is"}, {"id": "GNF090824", "relationship": "is"}, {"id": "GNF092511", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF050749", "relationship": "is"}, {"id": "GNF055511", "relationship": "is"}, {"id": "GNF060159", "relationship": "is"}, {"id": "GNF060749", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF065017", "relationship": "is"}, {"id": "GNF065018", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF095659", "relationship": "is"}, {"id": "GNF135316", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000002.12", "NC_060926.1", "NG_012798.1"], "protein": ["NP_001352465.1", "NP_002968.2", "XP_011509918.1", "XP_011509919.1", "XP_011509920.1", "XP_011509921.1", "XP_016860158.1", "XP_054199295.1", "XP_054199296.1", "XP_054199297.1", "XP_054199298.1", "XP_054199299.1", "XP_054199300.1", "XP_054199301.1"], "rna": ["NM_001365536.1", "NM_002977.4", "XM_011511616.4", "XM_011511617.3", "XM_011511618.3", "XM_011511619.3", "XM_017004669.2", "XM_054343320.1", "XM_054343321.1", "XM_054343322.1", "XM_054343323.1", "XM_054343324.1", "XM_054343325.1", "XM_054343326.1", "XR_001738886.2"], "translation": [{"protein": "XP_016860158.1", "rna": "XM_017004669.2"}, {"protein": "XP_054199298.1", "rna": "XM_054343323.1"}, {"protein": "XP_011509919.1", "rna": "XM_011511617.3"}, {"protein": "XP_011509921.1", "rna": "XM_011511619.3"}, {"protein": "XP_054199295.1", "rna": "XM_054343320.1"}, {"protein": "XP_054199301.1", "rna": "XM_054343326.1"}, {"protein": "XP_054199300.1", "rna": "XM_054343325.1"}, {"protein": "NP_001352465.1", "rna": "NM_001365536.1"}, {"protein": "XP_011509920.1", "rna": "XM_011511618.3"}, {"protein": "XP_011509918.1", "rna": "XM_011511616.4"}, {"protein": "NP_002968.2", "rna": "NM_002977.4"}, {"protein": "XP_054199297.1", "rna": "XM_054343322.1"}, {"protein": "XP_054199296.1", "rna": "XM_054343321.1"}, {"protein": "XP_054199299.1", "rna": "XM_054343324.1"}]}, "reporter": {"HG-U133_Plus_2": ["206950_at", "229199_at"], "HG-U95Av2": "32947_at", "HG-U95B": "57701_at", "HTA-2_0": ["TC02002499.hg.1", "TC02004675.hg.1", "TC02004676.hg.1"], "HuEx-1_0": "2585400", "HuGene-1_1": "8056491", "HuGene-2_1": "16904667"}, "retired": [8432, 93955], "summary": "This gene encodes a voltage-gated sodium channel which plays a significant role in nociception signaling. Mutations in this gene have been associated with primary erythermalgia, channelopathy-associated insensitivity to pain, and paroxysmal extreme pain disorder. [provided by RefSeq, Aug 2009].", "symbol": "SCN9A", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1419867"}, "unigene": "Hs.439145", "uniprot": {"Swiss-Prot": "Q15858", "TrEMBL": ["A0A590UJB2", "H7C064", "A0A0C4DG82", "A0A590UK23", "A0A2R8YCX9", "A0A2R8Y7G0"]}, "wikipedia": {"url_stub": "Nav1.7"}}